Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 15 other studies
246people with type 2 diabetes, in this paper
The trial randomly assignedassigned by chance
pioglitazone 30 mg/day add-on
placebo
Reported lower long-term blood sugar, no range given−0.80
randomisedthe abstract, start to end
… 24 weeks treatment reduced from 7.8%±0.8% to 7.0%±0.6% (P<0.0001).
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
HbA1cpioglitazone 30 mg/day add-on vs placebo
−0.80
ThiazolidinedionesGlycemic control
Thiazolidinediones × glycemic controlhelps?settled
unlikelylikely
0.830.80 without it
← favours treatmentfavours comparator →
1 / 6